Cargando…
Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential
Background: A preceding exploratory study (J. Clin. Pathol. 57(2004), 1201–1207) had shown that a karyometric assessment of nuclei from papillary urothelial neoplasms of low malignant potential (PUNLMP) revealed subtle differences in phenotype which correlated with recurrence of disease. Aim of the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617991/ https://www.ncbi.nlm.nih.gov/pubmed/17429141 http://dx.doi.org/10.1155/2007/356464 |
_version_ | 1782396870555860992 |
---|---|
author | Montironi, Rodolfo Scarpelli, Marina Lopez-Beltran, Antonio Mazzucchelli, Roberta Alberts, David Ranger-Moore, James Bartels, Hubert G. Hamilton, Peter W. Einspahr, Janine Bartels, Peter H. |
author_facet | Montironi, Rodolfo Scarpelli, Marina Lopez-Beltran, Antonio Mazzucchelli, Roberta Alberts, David Ranger-Moore, James Bartels, Hubert G. Hamilton, Peter W. Einspahr, Janine Bartels, Peter H. |
author_sort | Montironi, Rodolfo |
collection | PubMed |
description | Background: A preceding exploratory study (J. Clin. Pathol. 57(2004), 1201–1207) had shown that a karyometric assessment of nuclei from papillary urothelial neoplasms of low malignant potential (PUNLMP) revealed subtle differences in phenotype which correlated with recurrence of disease. Aim of the Study: To validate the results from the exploratory study on a larger sample size. Materials: 93 karyometric features were analyzed on haematoxylin and eosin-stained sections from 85 cases of PUNLMP. 45 cases were from patients who had a solitary PUNLMP lesion and were disease-free during a follow-up period of at least 8 years. The other 40 were from patients with a unifocal PUNLMP, with one or more recurrences in the follow-up. A combination of the previously defined classification functions together with a new P-index derived classification method was used in an attempt to classify cases and identify a biomarker of recurrence in PUNLMP lesions. Results: Validation was pursued by a number of separate approaches. First, the exact procedure from the exploratory study was applied to the large validation set. Second, since the discriminant function 2 of the exploratory study had been based on a small sample size, a new discriminant function was derived. The case classification showed a correct classification of 61% for non-recurrent and 74% for recurrent cases, respectively. Greater success was obtained by applying unsupervised learning technologies to take advantage of phenotypical composition (correct classification of 92%). This approach was validated by dividing the data into training and test sets with 2/3 of the cases assigned to the training sets, and 1/3 to the test sets, on a rotating basis, and validation of the classification rate was thus tested on three separate data sets by a leave-k-out process. The average correct classification was 92.8% (training set) and 84.6% (test set). Conclusions: Our validation study detected subvisual differences in chromatin organization state between non-recurrent and recurrent PUNLMP, thus allowing a very stable method of predicting recurrence of papillary urothelial neoplasms of low malignant potential by karyometry. |
format | Online Article Text |
id | pubmed-4617991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-46179912016-01-12 Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential Montironi, Rodolfo Scarpelli, Marina Lopez-Beltran, Antonio Mazzucchelli, Roberta Alberts, David Ranger-Moore, James Bartels, Hubert G. Hamilton, Peter W. Einspahr, Janine Bartels, Peter H. Cell Oncol Other Background: A preceding exploratory study (J. Clin. Pathol. 57(2004), 1201–1207) had shown that a karyometric assessment of nuclei from papillary urothelial neoplasms of low malignant potential (PUNLMP) revealed subtle differences in phenotype which correlated with recurrence of disease. Aim of the Study: To validate the results from the exploratory study on a larger sample size. Materials: 93 karyometric features were analyzed on haematoxylin and eosin-stained sections from 85 cases of PUNLMP. 45 cases were from patients who had a solitary PUNLMP lesion and were disease-free during a follow-up period of at least 8 years. The other 40 were from patients with a unifocal PUNLMP, with one or more recurrences in the follow-up. A combination of the previously defined classification functions together with a new P-index derived classification method was used in an attempt to classify cases and identify a biomarker of recurrence in PUNLMP lesions. Results: Validation was pursued by a number of separate approaches. First, the exact procedure from the exploratory study was applied to the large validation set. Second, since the discriminant function 2 of the exploratory study had been based on a small sample size, a new discriminant function was derived. The case classification showed a correct classification of 61% for non-recurrent and 74% for recurrent cases, respectively. Greater success was obtained by applying unsupervised learning technologies to take advantage of phenotypical composition (correct classification of 92%). This approach was validated by dividing the data into training and test sets with 2/3 of the cases assigned to the training sets, and 1/3 to the test sets, on a rotating basis, and validation of the classification rate was thus tested on three separate data sets by a leave-k-out process. The average correct classification was 92.8% (training set) and 84.6% (test set). Conclusions: Our validation study detected subvisual differences in chromatin organization state between non-recurrent and recurrent PUNLMP, thus allowing a very stable method of predicting recurrence of papillary urothelial neoplasms of low malignant potential by karyometry. IOS Press 2007 2007-04-03 /pmc/articles/PMC4617991/ /pubmed/17429141 http://dx.doi.org/10.1155/2007/356464 Text en Copyright © 2007 Hindawi Publishing Corporation and the authors. |
spellingShingle | Other Montironi, Rodolfo Scarpelli, Marina Lopez-Beltran, Antonio Mazzucchelli, Roberta Alberts, David Ranger-Moore, James Bartels, Hubert G. Hamilton, Peter W. Einspahr, Janine Bartels, Peter H. Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential |
title | Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential |
title_full | Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential |
title_fullStr | Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential |
title_full_unstemmed | Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential |
title_short | Chromatin Phenotype Karyometry Can Predict Recurrence in Papillary Urothelial Neoplasms of Low Malignant Potential |
title_sort | chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential |
topic | Other |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617991/ https://www.ncbi.nlm.nih.gov/pubmed/17429141 http://dx.doi.org/10.1155/2007/356464 |
work_keys_str_mv | AT montironirodolfo chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT scarpellimarina chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT lopezbeltranantonio chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT mazzucchelliroberta chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT albertsdavid chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT rangermoorejames chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT bartelshubertg chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT hamiltonpeterw chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT einspahrjanine chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential AT bartelspeterh chromatinphenotypekaryometrycanpredictrecurrenceinpapillaryurothelialneoplasmsoflowmalignantpotential |